Ranked #1
Large disparities found in BCRA testing across ethnicities - Dr Tuya Pal
Large disparities found in BCRA testing across ethnicities - Dr Tuya Pal
Dr Pal talks to ecancertv at ASCO 2016 about a study that looked at the uptake of BRCA genetic tests among young cancer ... Read more
30 Jul 2016
•
10mins
Ranked #2
METEOR trial: cabozantinib vs everolimus in advanced renal cell carcinoma - Dr Toni Choueiri
METEOR trial: cabozantinib vs everolimus in advanced renal cell carcinoma - Dr Toni Choueiri
Dr Choueiri speaks with ecancertv at ASCO 2016 about results from METEOR, a randomised phase III trial of cabozantinib f... Read more
30 Jul 2016
•
5mins
Ranked #3
Temozolomide after radiotherapy improves glioma survival - Dr Martin van den Bent
Temozolomide after radiotherapy improves glioma survival - Dr Martin van den Bent
Dr Van Den Bent presents at ASCO 2016 about the phase III trial, which showed that patients with anaplastic glioma witho... Read more
30 Jul 2016
•
5mins
Ranked #4
Performance characteristics and stage distribution of invasive epithelial ovarian/tubal/peritoneal cancers - Prof Usha Menon
Performance characteristics and stage distribution of invasive epithelial ovarian/tubal/peritoneal cancers - Prof Usha Menon
Professor Menon speaks with ecancertv at ASCO 2016 about screening strategies to detect early stage ovarian cancer.Ovari... Read more
30 Jul 2016
•
4mins
Most Popular Podcasts
The Joe Rogan Experience
TED Talks Daily
The Tim Ferriss Show
The Daily
Stuff You Should Know
Oprah's SuperSoul Conversations
Armchair Expert with Dax Shepard
Ranked #5
Latest in precision cancer medicine - Prof Richard Schilsky
Latest in precision cancer medicine - Prof Richard Schilsky
Prof Schilsky talks to ecancertv at ASCO 2016 about the latest in precision medicine.
30 Jul 2016
•
5mins
Ranked #6
Radiotherapy modalities for locally advanced non-small cell lung cancer - Dr Zhongxing Liao
Radiotherapy modalities for locally advanced non-small cell lung cancer - Dr Zhongxing Liao
Dr Liao talks to ecancertv at ASCO 2016 about the results of a Bayesian randomised trial comparing intensity modulated r... Read more
30 Jul 2016
•
5mins
Ranked #7
Advaned RET-rearranged NSCLC - Takashi Seto and Kiyotaka Yoh
Advaned RET-rearranged NSCLC - Takashi Seto and Kiyotaka Yoh
Dr Seto (National Kyushu Cancer Center, Kyushu, Japan) and Dr Yoh (National Cancer Center Hospital East, Kashiwa, Japan)... Read more
30 Jul 2016
•
3mins
Ranked #8
Developments in haematological malignancies - Dr Stephen Nimer
Developments in haematological malignancies - Dr Stephen Nimer
Dr Nimer meets with ecancertv at ASCO 2016 to discuss haematological malignancies.
30 Jul 2016
•
4mins
Ranked #9
Recent developments in targeted therapies - Dr Stephen Nimer
Recent developments in targeted therapies - Dr Stephen Nimer
Dr Nimer speaks with ecancertv at ASCO 2016 about tumour heterogeneity.Personalised and targeted therapies have offered ... Read more
30 Jul 2016
•
4mins
Ranked #10
Novel antibody helps patients with advanced gastric cancer live longer - Prof Salah-Eddin Al-Batran
Novel antibody helps patients with advanced gastric cancer live longer - Prof Salah-Eddin Al-Batran
Prof Al-Batran talks to ecancertv at ASCO 2016 about findings from a European phase II study which showed that the novel... Read more
30 Jul 2016
•
8mins
